Skip to Content
Merck
CN
  • GWAS for Interleukin-1β levels in gingival crevicular fluid identifies IL37 variants in periodontal inflammation.

GWAS for Interleukin-1β levels in gingival crevicular fluid identifies IL37 variants in periodontal inflammation.

Nature communications (2018-09-13)
Steven Offenbacher, Yizu Jiao, Steven J Kim, Julie Marchesan, Kevin L Moss, Li Jing, Kimon Divaris, Sompop Bencharit, Cary S Agler, Thiago Morelli, Shaoping Zhang, Lu Sun, William T Seaman, Dale Cowley, Silvana P Barros, James D Beck, Matthias Munz, Arne S Schaefer, Kari E North
ABSTRACT

There is no agnostic GWAS evidence for the genetic control of IL-1β expression in periodontal disease. Here we report a GWAS for "high" gingival crevicular fluid IL-1β expression among 4910 European-American adults and identify association signals in the IL37 locus. rs3811046 at this locus (p = 3.3 × 10-22) is associated with severe chronic periodontitis (OR = 1.50; 95% CI = 1.12-2.00), 10-year incident tooth loss (≥3 teeth: RR = 1.33; 95% CI = 1.09-1.62) and aggressive periodontitis (OR = 1.12; 95% CI = 1.01-1.26) in an independent sample of 4927 German/Dutch adults. The minor allele at rs3811046 is associated with increased expression of IL-1β in periodontal tissue. In RAW macrophages, PBMCs and transgenic mice, the IL37 variant increases expression of IL-1β and IL-6, inducing more severe periodontal disease, while IL-37 protein production is impaired and shows reduced cleavage by caspase-1. A second variant in the IL37 locus (rs2708943, p = 4.2 × 10-7) associates with attenuated IL37 mRNA expression. Overall, we demonstrate that IL37 variants modulate the inflammatory cascade in periodontal disease.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Cytokeratin 5 Antibody, 6, clone D5/16B4, clone D5/16B4, Chemicon®, from mouse